AAAAAA

   
Results: 1-18 |
Results: 18
The antitumour agent 5,6-dimethylxanthenone-4-acetic acid acts in vitro onhuman mononuclear cells as a co-stimulator with other inducers of tumour necrosis factor
Authors: Philpott, M Ching, LM Baguley, BC
Citation: M. Philpott et al., The antitumour agent 5,6-dimethylxanthenone-4-acetic acid acts in vitro onhuman mononuclear cells as a co-stimulator with other inducers of tumour necrosis factor, EUR J CANC, 37(15), 2001, pp. 1930-1937
Effects of the serotonin receptor antagonist cyproheptadine on the activity and pharmacokinetics of 5,6-dimethylxanthenone-4-acetic acid (DMXAA)
Authors: Zhao, LL Kestell, P Philpott, M Ching, LM Zhuang, L Baguley, BC
Citation: Ll. Zhao et al., Effects of the serotonin receptor antagonist cyproheptadine on the activity and pharmacokinetics of 5,6-dimethylxanthenone-4-acetic acid (DMXAA), CANC CHEMOT, 47(6), 2001, pp. 491-497
A difference between the rat and mouse in the pharmacokinetic interaction of 5,6-dimethylxanthenone-4-acetic acid with thalidomide
Authors: Zhou, SF Kestell, P Tingle, MD Ching, LM Paxton, JW
Citation: Sf. Zhou et al., A difference between the rat and mouse in the pharmacokinetic interaction of 5,6-dimethylxanthenone-4-acetic acid with thalidomide, CANC CHEMOT, 47(6), 2001, pp. 541-544
In vitro and in vivo kinetic interactions of the antitumour agent 5,6-dimethylxanthenone-4-acetic acid with thalidomide and diclofenac
Authors: Zhou, S Paxton, JW Kestell, P Tingle, MD Ching, LM
Citation: S. Zhou et al., In vitro and in vivo kinetic interactions of the antitumour agent 5,6-dimethylxanthenone-4-acetic acid with thalidomide and diclofenac, CANC CHEMOT, 47(4), 2001, pp. 319-326
Vascular attack by 5,6-dimethylxanthenone-4-acetic acid combined with B7.1(CD80)-mediated immunotherapy overcomes immune resistance and leads to theeradication of large tumors and multiple tumor foci
Authors: Kanwar, JR Kanwar, RK Pandey, S Ching, LM Krissansen, GW
Citation: Jr. Kanwar et al., Vascular attack by 5,6-dimethylxanthenone-4-acetic acid combined with B7.1(CD80)-mediated immunotherapy overcomes immune resistance and leads to theeradication of large tumors and multiple tumor foci, CANCER RES, 61(5), 2001, pp. 1948-1956
Interferon-inducible protein 10 induction and inhibition of angiogenesis in vivo by the antitumor agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA)
Authors: Cao, ZH Baguley, BC Ching, LM
Citation: Zh. Cao et al., Interferon-inducible protein 10 induction and inhibition of angiogenesis in vivo by the antitumor agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA), CANCER RES, 61(4), 2001, pp. 1517-1521
Modulation of the pharmacokinetics of the antitumour agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in mice by thalidomide
Authors: Kestell, P Zhao, LL Baguley, BC Palmer, BD Muller, G Paxton, JW Ching, LM
Citation: P. Kestell et al., Modulation of the pharmacokinetics of the antitumour agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in mice by thalidomide, CANC CHEMOT, 46(2), 2000, pp. 135-141
Translocation (1;13)(p34;q32) in childhood pre-B-cell acute lymphoblastic leukemia
Authors: Wan, TSK Ma, SK Ching, LM Chan, LC Chan, GCF Ha, SY
Citation: Tsk. Wan et al., Translocation (1;13)(p34;q32) in childhood pre-B-cell acute lymphoblastic leukemia, CANC GENET, 121(1), 2000, pp. 107-108
Cytogenetic characterization of childhood hepatoblastoma
Authors: Ma, SK Cheung, ANY Choy, C Chan, GCF Ha, SY Ching, LM Wan, TSK Chan, LC
Citation: Sk. Ma et al., Cytogenetic characterization of childhood hepatoblastoma, CANC GENET, 119(1), 2000, pp. 32-36
Complex cytogenetic abnormalities in T-lymphoblastic lymphoma: Resolution by spectral karyotyping
Authors: Wan, TSK Ma, SK Chan, GCF Ching, LM Ha, SY Chan, LC
Citation: Tsk. Wan et al., Complex cytogenetic abnormalities in T-lymphoblastic lymphoma: Resolution by spectral karyotyping, CANC GENET, 118(1), 2000, pp. 24-27
Acute myeloid leukaemia with giant granules: association with t(10;11)(p13; q14) and disseminated intravascular coagulation
Authors: Ma, SK Yip, SF Wan, TSK Shek, TWH Ching, LM Yeung, YM
Citation: Sk. Ma et al., Acute myeloid leukaemia with giant granules: association with t(10;11)(p13; q14) and disseminated intravascular coagulation, CLIN LAB H, 22(5), 2000, pp. 303-305
Inhibition of tumor blood flow
Authors: Ching, LM Wilson, WR Baguley, BC
Citation: Lm. Ching et al., Inhibition of tumor blood flow, METH MOL M, 25, 2000, pp. 133-157
A novel t(1;10)(q32;p12) in acute myelomonocytic leukemia
Authors: Wan, TSK Ma, SK Ching, LM Chan, LC Mak, YK
Citation: Tsk. Wan et al., A novel t(1;10)(q32;p12) in acute myelomonocytic leukemia, CANC GENET, 114(1), 1999, pp. 85-86
Stimulation of tumors to synthesize tumor necrosis factor-alpha in situ using 5,6-dimethylxanthenone-4-acetic acid: A novel approach to cancer therapy
Authors: Joseph, WR Cao, ZH Mountjoy, KG Marshall, ES Baguley, BC Ching, LM
Citation: Wr. Joseph et al., Stimulation of tumors to synthesize tumor necrosis factor-alpha in situ using 5,6-dimethylxanthenone-4-acetic acid: A novel approach to cancer therapy, CANCER RES, 59(3), 1999, pp. 633-638
Induction of intratumoral tumor necrosis factor (TNF) synthesis and hemorrhagic necrosis by 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in TNF knockout mice
Authors: Ching, LM Goldsmith, D Joseph, WR Korner, H Sedgwick, JD Baguley, BC
Citation: Lm. Ching et al., Induction of intratumoral tumor necrosis factor (TNF) synthesis and hemorrhagic necrosis by 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in TNF knockout mice, CANCER RES, 59(14), 1999, pp. 3304-3307
Thalidomide increases both intra-tumoural tumour necrosis factor-alpha production and anti-tumour activity in response to 5,6-dimethylxanthenone-4-acetic acid
Authors: Cao, Z Joseph, WR Browne, WL Mountjoy, KG Palmer, BD Baguley, BC Ching, LM
Citation: Z. Cao et al., Thalidomide increases both intra-tumoural tumour necrosis factor-alpha production and anti-tumour activity in response to 5,6-dimethylxanthenone-4-acetic acid, BR J CANC, 80(5-6), 1999, pp. 716-723
Induction of STAT and NF kappa B activation by the antitumor agents 5,6-dimethylxanthenone-4-acetic acid and flavone acetic acid in a murine macrophage cell line
Authors: Ching, LM Young, HA Eberly, K Yu, CR
Citation: Lm. Ching et al., Induction of STAT and NF kappa B activation by the antitumor agents 5,6-dimethylxanthenone-4-acetic acid and flavone acetic acid in a murine macrophage cell line, BIOCH PHARM, 58(7), 1999, pp. 1173-1181
Suppression of serum tumour necrosis factor-alpha by thalidomide does not lead to reversal of tumour vascular collapse and anti-tumour activity of 5,6-dimethylxanthenone-4-acetic acid
Authors: Browne, WL Wilson, WR Baguley, BC Ching, LM
Citation: Wl. Browne et al., Suppression of serum tumour necrosis factor-alpha by thalidomide does not lead to reversal of tumour vascular collapse and anti-tumour activity of 5,6-dimethylxanthenone-4-acetic acid, ANTICANC R, 18(6A), 1998, pp. 4409-4413
Risultati: 1-18 |